Kura Oncology KURA Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Operating margin | -449.9%-91.4pp | -358.5%— | —— | —— | |
| Net margin | -412.9%-90.1pp | -322.9%— | —— | —— | |
| EBITDA margin | -448.4%-91.4pp | -357%— | —— | —— | |
| Returns | |||||
| Return on equity | -94.8%-51.9pp | -42.9%-5.6pp | -37.3%-8.0pp | -29.3%-6.0pp | |
| Return on assets | -37.2%-8.4pp | -28.8%+4.9pp | -33.7%-6.3pp | -27.4%-5.3pp | |
| Return on invested capital | -241.7%-175pp | -66.3%-22.6pp | -43.7%-8.9pp | -34.7%— | |
| Efficiency | |||||
| Asset turnover | 0.1×0.0× | 0.1×— | 0×— | —— | |
| Liquidity | |||||
| Current ratio | 6.1×-3.4× | 9.5×-2.8× | 12.3×-6.3× | 18.6×-4.7× | |
| Quick ratio | 6.1×-3.4× | 9.5×-2.8× | 12.3×-6.3× | 18.6×-4.7× | |
| Cash ratio | 1.3×-1.6× | 2.9×+1.8× | 1.1×-1.1× | 2.2×-1.9× | |
| Leverage | |||||
| Debt-to-equity | 0.1×+0.1× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Interest coverage | -200.8×-81.5× | -119.3×-12.3× | -107×+504× | -610.8×— | |
| Per Share | |||||
| Book value per share | $1.99-58.6% | $4.80-11.5% | $5.43-13.5% | $6.27-17.8% | |
| Valuation | |||||
| Market capitalization | $919.7M+81.6% | $677.32M-39.1% | $1.11B+32.2% | $841.16M-9.8% | |
| Enterprise value | $904.89M+90.7% | $469.45M-57.0% | $1.09B+35.9% | $803.38M-5.3% | |
| Price / sales | 12.8×+3.5× | 12.6×— | —— | —— | |
| Price / book | 8.5×+7.1× | 1.6×-1.2× | 2.8×+0.8× | 2×+0.2× | |
| EV / sales | 12.6×+3.9× | 8.7×— | —— | —— | |
| Earnings yield | -32%+3.9pp | -25.7%-12.0pp | -13.7%+2.4pp | -16.1%-2.2pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Kura Oncology's ratios come from?
- Every ratio is computed from Kura Oncology's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
